Mallinckrodt Ard patents expiration
1. Acthar Gel patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11752199 | MALLINCKRODT ARD | Methods of modulating pericytes |
Feb, 2041
(16 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Oct 15, 2017 |
Drugs and Companies using CORTICOTROPIN ingredient
Treatment: Treatment of ophthalmic diseases with corticotropin by promoting new vessel formation wherein vcam-1 expression and angiopoetin-2 expression is increased after the administering
Dosage: INJECTABLE;INJECTION
More Information on Dosage
ACTHAR GEL family patents
